Pharma Pulse 3/10/25: NIH’s Role in New Drug Development, Future Directions in Biosimilar Health Care Delivery & more

The NIH’s Role in New Drug Development

Dr. Hernan Bazan, CEO of South Rampart Pharma, discusses his company’s current pipeline.

Perspectives and Future Directions in Biosimilar Health Care Delivery

A panelist discusses how managing biosimilars requires close collaboration between payers and health systems to optimize patient care and cost savings, while sharing insights about program implementation challenges across different care settings and emphasizing the importance of robust operational frameworks.

Turing Award Goes to Pioneers of Artificial Intelligence

Andrew Barto and Richard Sutton developed reinforcement learning, a technique vital to chatbots like ChatGPT.

Bristol Myers Squibb Receives European Commission Approval for Opdivo^® plus Yervoy^®

Bristol Myers Squibb has announced that the European Commission (EC) has approved Opdivo^® (nivolumab) plus Yervoy^® (ipilimumab) for the first-line treatment of adult patients with unresectable or advanced hepatocellular carcinoma.

Jon Paul Pedigo-Gomez on LinkedIn
Tom Dorsett is wealth of knowledge. Great content.

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs